1 Correction to: Drug Safety https://doi.org/10.1007/s40264-020-00932-5
The article “Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands”, written by Linda Härmark, Gerda Weits, Rietje Meijer, Federica Santoro, G. Niklas Norén, Florence van Hunsel, was originally published electronically on 16 May 2020 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 12 June 2020 to © The Author(s) 2020 and the article is forthwith distributed under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The original version of this article was revised due to a retrospective Open Access order.
About this article
Cite this article
Härmark, L., Weits, G., Meijer, R. et al. Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands. Drug Saf 43, 823 (2020). https://doi.org/10.1007/s40264-020-00970-z